Search
Search Results
##search.searchResults.foundPlural##
-
Is laboratory monitoring useful in DOACs management?
889PDF: 833HTML: 114 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3446PDF: 1392HTML: 2712 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1537PDF: 912HTML: 376 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1630PDF: 516MP4: 435Html: 254 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4389PDF: 1406HTML: 2180 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2908PDF: 1026HTML: 771 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4345PDF: 1548HTML: 463 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1385PDF: 600Suppl. Files: 365HTML: 166 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2893PDF: 1042HTML: 5631 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4519PDF: 1509HTML: 8527 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4843PDF: 1586HTML: 2255Untitled: 237Untitled: 253Untitled: 275Untitled: 231Untitled: 242 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2879PDF: 1858HTML: 3766Pellagatti Fig 1: 233Pellagatti Fig. 2: 230 -
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1355PDF: 764HTML: 400 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3566PDF: 1326HTML: 2026Fig.1: 226Fig. 2: 223 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7759PDF: 2462HTML: 2102Table 1.: 234Table 2.: 243Table 3.: 226Table 4.: 219 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2526HTML: 294PDF: 926 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4625PDF: 1970HTML: 18044 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1829PDF: 597HTML: 340 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4132PDF: 1177HTML: 2101Fig.1: 224Fig. 2: 120Table 1: 215Table2: 233Table 3: 212 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3441PDF: 1506HTML: 4077 -
Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine
2190PDF: 602HTML: 1165 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3126PDF: 900HTML: 7293Kost Fig1: 204Kost Fig 2: 193Kost Fig3: 196Kost Fig 4: 208Kost Fig5: 207Kost fig 6: 193 -
-
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2438PDF: 1021HTML: 1656Fig 1: 202Tab I: 227Cover Letter: 222 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2239PDF: 1645HTML: 402 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5255PDF: 1363HTML: 2863Cover letter: 215 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1644PDF: 824HTML: 1275Figure 1: 187Figure 2: 201Figure 3: 198 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4922PDF: 2906HTML: 2325 -
How I treat acute and persistent sickle cell pain
2031PDF: 1144HTML: 647







